3rd Quarter - Amendment — TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC (2010)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

TEVA PHARMACEUTICALS USA, INC.

Client

TEVA PHARMACEUTICALS USA INC

Income

—

Expenses

$580,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
3rd Quarter - Report	Oct 20, 2010	$840,000	Replaced
3rd Quarter - Amendment (this page)	Oct 25, 2010	$580,000	Replaced
3rd Quarter - Amendment	Oct 26, 2010	$610,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT JOHN CLARK	Staff Assist., Rep. Frank Pallone (2003-04)
TERRI STEWART	—

Contacted: U.S. Customs & Border Protection; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Health Issues HCR

H.R. 5561/S.3504, Emergency Contraception Education Act (increased Office of Generic Drugs funding) .

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT FALB	—
TERRI STEWART	—

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); U.S. Customs & Border Protection

Bills named: S. 3504 (111th), H.R. 5561 (111th)

Copyright/Patent/Trademark CPT

H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT JOHN CLARK	Staff Assist., Rep. Frank Pallone (2003-04)
ROBERT FALB	—
TERRI STEWART	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Customs & Border Protection; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO)

Bills named: H.R. 1260 (111th), H.R. 1706 (111th), S. 610 (111th), S. 515 (111th), S. 369 (111th), S. 1315 (111th)

Pharmacy PHA

H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT JOHN CLARK	Staff Assist., Rep. Frank Pallone (2003-04)
ROBERT FALB	—
TERRI STEWART	—

Contacted: SENATE; U.S. Customs & Border Protection; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 1859 (111th), S. 767 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.